We are live on ! Find out more
SCM

Soleus Capital Management Portfolio holdings

AUM $2.47B
1-Year Est. Return 115.63%
This Fund
S&P 500
This Quarter Est. Return
+82.83%
1 Year Est. Return
+115.63%
3 Year Est. Return
+435.52%
5 Year Est. Return
+604.31%
10 Year Est. Return
–
AUM
$104M
AUM Growth
–
Cap. Flow
+$89.1M
Cap. Flow %
85.97%
Top 10 Hldgs %
53.66%
Holding
49
New
49
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GRFS
Grifois
GRFS
+$9.87M
2
EPIX
ESSA Pharma
EPIX
+$7.6M
3
WMGI
Wright Medical Group Inc
WMGI
+$5.94M
4
AGN
Allergan plc
AGN
+$5.14M
5
SYRE icon
Spyre Therapeutics
SYRE
+$3.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 96.31%
2 Real Estate 0.65%
3 Communication Services 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STE icon
26
Steris
STE
$22.3B
$1.34M 1.29%
+8,800
New +$1.29M
STAA icon
27
STAAR Surgical
STAA
$1.2B
$1.26M 1.22%
+35,940
New +$1.19M
ZYME icon
28
Zymeworks
ZYME
$1.61B
$1.03M 0.99%
+22,700
New +$825K
NVRO
29
DELISTED
NEVRO CORP.
NVRO
$969K 0.93%
+8,246
New +$817K
LRMR icon
30
Larimar Therapeutics
LRMR
$394M
$892K 0.86%
+66,997
New +$640K
ZEAL
31
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$892K 0.86%
+26,882
New +$803K
ICAD
32
DELISTED
iCAD Inc
ICAD
$737K 0.71%
+94,900
New +$677K
FLXN
33
DELISTED
Flexion Therapeutics, Inc.
FLXN
$722K 0.7%
+34,900
New +$589K
RFL icon
34
Rafael Holdings
RFL
$100M
$676K 0.65%
+38,456
New +$701K
INSP icon
35
Inspire Medical Systems
INSP
$1.44B
$668K 0.64%
+9,008
New +$579K
ARNA
36
DELISTED
Arena Pharmaceuticals Inc
ARNA
$504K 0.49%
+11,100
New +$525K
TNDM icon
37
Tandem Diabetes Care
TNDM
$1.34B
$453K 0.44%
+7,600
New +$469K
NTRA icon
38
Natera
NTRA
$38.2B
$437K 0.42%
+13,000
New +$479K
LVGO
39
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$422K 0.41%
+16,866
New +$403K
ESPR
40
DELISTED
Esperion Therapeutics
ESPR
$399K 0.38%
+6,700
New +$301K
GH icon
41
Guardant Health
GH
$21.4B
$382K 0.37%
+4,900
New +$353K
RVNC
42
DELISTED
Revance Therapeutics, Inc.
RVNC
$376K 0.36%
+23,200
New +$360K
ARVN icon
43
Arvinas
ARVN
$516M
$357K 0.34%
+8,700
New +$255K
PTCT icon
44
PTC Therapeutics
PTCT
$5.65B
$326K 0.31%
+6,800
New +$289K
ARGX icon
45
argenx
ARGX
$53.5B
$240K 0.23%
+1,500
New +$203K
SWAV
46
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$237K 0.23%
+5,400
New +$199K
DRNA
47
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$235K 0.23%
+10,700
New +$215K
FATE icon
48
Fate Therapeutics
FATE
$287M
$223K 0.22%
+11,400
New +$181K
SNDX icon
49
Syndax Pharmaceuticals
SNDX
$1.68B
$184K 0.18%
+20,980
New +$154K
1
2

Similar funds

TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
BW
BIP Wealth Atlanta, Georgia $2.46B AUM 14.38% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Q
QVR San Francisco, California $2.49B AUM 48.58% 1-Year Est. Return

Soleus Capital Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Soleus Capital Management, which disclosed 49 positions worth $104M. Its ten largest holdings account for 54% of the portfolio.

Its largest position is Grifois: 452,900 shares worth $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, followed by Real Estate and Communication Services.

  • Soleus Capital Management's largest Q4 2019 buy was Grifois: 452,900 shares worth $10.5M.
  • Soleus Capital Management's ten largest holdings make up 54% of its $104M portfolio in Q4 2019.
  • Soleus Capital Management disclosed 49 positions in Q4 2019, its first 13F filing on record.

Based on Soleus Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.